These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25004816)

  • 1. IL-10: achieving balance during persistent viral infection.
    Ng CT; Oldstone MB
    Curr Top Microbiol Immunol; 2014; 380():129-44. PubMed ID: 25004816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective and detrimental roles of IL-10 in HIV pathogenesis.
    Kwon DS; Kaufmann DE
    Eur Cytokine Netw; 2010 Sep; 21(3):208-14. PubMed ID: 20732847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.
    Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.
    Cunningham CR; Champhekar A; Tullius MV; Dillon BJ; Zhen A; de la Fuente JR; Herskovitz J; Elsaesser H; Snell LM; Wilson EB; de la Torre JC; Kitchen SG; Horwitz MA; Bensinger SJ; Smale ST; Brooks DG
    PLoS Pathog; 2016 Jan; 12(1):e1005356. PubMed ID: 26808628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10: A Multifunctional Cytokine in Viral Infections.
    Rojas JM; Avia M; Martín V; Sevilla N
    J Immunol Res; 2017; 2017():6104054. PubMed ID: 28316998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10, T cell exhaustion and viral persistence.
    Blackburn SD; Wherry EJ
    Trends Microbiol; 2007 Apr; 15(4):143-6. PubMed ID: 17336072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Networking at the level of host immunity: immune cell interactions during persistent viral infections.
    Ng CT; Snell LM; Brooks DG; Oldstone MB
    Cell Host Microbe; 2013 Jun; 13(6):652-64. PubMed ID: 23768490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.
    Pellegrini M; Calzascia T; Toe JG; Preston SP; Lin AE; Elford AR; Shahinian A; Lang PA; Lang KS; Morre M; Assouline B; Lahl K; Sparwasser T; Tedder TF; Paik JH; DePinho RA; Basta S; Ohashi PS; Mak TW
    Cell; 2011 Feb; 144(4):601-13. PubMed ID: 21295337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1.
    Parish IA; Marshall HD; Staron MM; Lang PA; Brüstle A; Chen JH; Cui W; Tsui YC; Perry C; Laidlaw BJ; Ohashi PS; Weaver CT; Kaech SM
    J Clin Invest; 2014 Aug; 124(8):3455-68. PubMed ID: 25003188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21 is required to control chronic viral infection.
    Elsaesser H; Sauer K; Brooks DG
    Science; 2009 Jun; 324(5934):1569-72. PubMed ID: 19423777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling viral and immune system dynamics.
    Perelson AS
    Nat Rev Immunol; 2002 Jan; 2(1):28-36. PubMed ID: 11905835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection.
    Lewis GM; Macal M; Hesser CR; Zuñiga EI
    J Virol; 2015 Mar; 89(6):3343-55. PubMed ID: 25589641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive mechanisms during viral infectious diseases.
    Sarikonda G; von Herrath MG
    Methods Mol Biol; 2011; 677():431-47. PubMed ID: 20941625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating insights from persistent LCMV infection into anti-HIV immunity.
    Wilson EB; Brooks DG
    Immunol Res; 2010 Dec; 48(1-3):3-13. PubMed ID: 20725865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic depletion of natural killer cells controls persistent infection.
    Waggoner SN; Daniels KA; Welsh RM
    J Virol; 2014 Feb; 88(4):1953-60. PubMed ID: 24284324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early virus-host interactions dictate the course of a persistent infection.
    Sullivan BM; Teijaro JR; de la Torre JC; Oldstone MB
    PLoS Pathog; 2015 Jan; 11(1):e1004588. PubMed ID: 25569216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A-Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection.
    Liang Y; Yi P; Wang X; Zhang B; Jie Z; Soong L; Sun J
    J Immunol; 2020 Jun; 204(11):2984-2994. PubMed ID: 32284332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of interleukin-37 in infectious diseases.
    Allam G; Gaber AM; Othman SI; Abdel-Moneim A
    Int Rev Immunol; 2020; 39(1):3-10. PubMed ID: 31633447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.